Who is sponsoring NCT03287154?

NCT03287154 is sponsored by Centre Hospitalier Henri Laborit.

What drugs are being tested in NCT03287154?

Interventions in NCT03287154: Active tDCS stimulations, Sham tDCS.

What condition does NCT03287154 study?

NCT03287154 studies Alcoholic Intoxication.

Is NCT03287154 still recruiting?

NCT03287154 is currently completed. Last updated 13 January 2026.

Last reviewed 2026-01-13 · How we verify

NCT03287154: ITAMAA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interest of tDCS in Help for Supporting Alcohol Abstinence

Completed NA Last updated 13 January 2026

What this trial tests

NA trial testing Active tDCS stimulations in Alcoholic Intoxication in 90 participants. Completed in 7 August 2025.

Timeline

8 February 2017

Primary endpoint
7 February 2025

7 August 2025

Quick facts

Lead sponsor	Centre Hospitalier Henri Laborit
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	90
Start date	8 February 2017
Primary completion	7 February 2025
Estimated completion	7 August 2025
Sites	2 locations across France

Drugs / interventions tested

Active tDCS stimulations
Sham tDCS

Conditions studied

Alcoholic Intoxication — all drugs for Alcoholic Intoxication →

Sponsor

Centre Hospitalier Henri Laborit

Who can join

Adults 18 to 70, any sex, with Alcoholic Intoxication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate in patients with alcohol disorder and forehand weaned the efficiency of 10 active tDCS sessions versus 10 sham (placebo) sessions in the support of abstinence at 3 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Henri Laborit trials

Trials by the same sponsor.

NCT07429500 — tDCS and Symptom Provocation in Treatment-Resistant OCD · NA · not yet recruiting
NCT07015502 — Self-Dehumanization and Hesitation to Report Domestic Violence · recruiting
NCT07274722 — Influence of Control Deprivation on the Use of the Analytical Cognitive Style in Anorexic Subjects · NA · recruiting
NCT06093919 — Study of Prevalence of Eating Disorder in Liver Transplant Patients · completed
NCT06009523 — Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03287154 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Henri Laborit
Last refreshed: 13 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03287154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing